The Epoch Times The Omicron variant of the CCP (Chinese Communist Party) virus can best the antibodies from Pfizer’s COVID-19 vaccine, according to a newly released small study led by South African researchers.
Samples of plasma drawn from 12 people who received the Pfizer-BioNTech vaccine were tested as part of a rapid response to the variant, which recently emerged in Africa and has triggered travel bans across the world.
The results? A 41-fold decline in antibodies.
The research suggests the variant “escapes antibody immunity induced by the Pfizer-BioNTech vaccine,” the Africa Health Research Institute said.
Several scientists with the research, based in Durban, collaborated on the study with other researchers in Africa…
